Literature DB >> 26426709

The Effect of Smoking on Spinal Cord Healing Following Surgical Treatment of Cervical Myelopathy.

David J Kusin1, Uri M Ahn, Nicholas U Ahn.   

Abstract

STUDY
DESIGN: Retrospective cohort.
OBJECTIVE: The purpose of this study was to compare outcomes of surgical treatment of cervical myelopathy between smokers and nonsmokers as assessed by the Nurick score. SUMMARY OF BACKGROUND DATA: The harmful effects of smoking on healing have been well established. However, the effect of smoking on postoperative outcomes for cervical myelopathy has not been specifically evaluated.
METHODS: The medical records of 212 patients who underwent surgery for cervical spondylotic myelopathy were reviewed. Inclusion criteria were the diagnosis of cervical spondylotic myelopathy with a Nurick score, surgical intervention, and at least 2 years of follow-up. The patients were categorized into 2 groups according to smoking status and stratified according to pack years and packs per day. Age at presentation, sex, preoperative and postoperative Nurick score, duration of symptoms preoperatively, duration of follow-up, procedure performed, surgical approach, number of levels fused, diabetes status, cocaine use, ethanol use, preoperative magnetic resonance imaging signal change, and whether the patient belonged to the Veterans Administration (VA) were recorded. Analysis was done using simple linear regression and multiple regression.
RESULTS: Univariate analysis demonstrated a postoperative improvement in nonsmokers of 1.53 points on the Nurick scale compared with 0.6 points in smokers (P < 0.001). There is a progressive decrease in improvement as the number of pack years and packs per day increase (P < 0.001). There is a greater improvement in Nurick score with greater (worse) preoperative score but only in patients with fewer than 25 pack years. Smoking status is not associated with preoperative Nurick score.
CONCLUSION: Smoking status is associated with poor improvement in Nurick score after surgical treatment of cervical myelopathy. Smoking may have a directly toxic effect on the intrinsic healing capability of the spinal cord, particularly beyond 25 pack years. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2015        PMID: 26426709     DOI: 10.1097/BRS.0000000000001014

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  No Difference in Functional Outcome but Higher Revision Rate Among Smokers Undergoing Cervical Artificial Disc Replacement: Analysis of a Spine Registry.

Authors:  Lee Wen-Shen; Maksim Lai Wern Sheng; William Yeo; Tan Seang Beng; Yue Wai Mun; Guo Chang Ming; Mohammad Mashfiqul Arafin Siddiqui
Journal:  Int J Spine Surg       Date:  2020-12-29

2.  Trends analysis of surgical procedures for cervical degenerative disc disease and myelopathy in patients with tobacco use disorder.

Authors:  Phillip Grisdela; Zorica Buser; Anthony D'Oro; Permsak Paholpak; John C Liu; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2017-05-09       Impact factor: 3.134

3.  The Utility of Cervical Spine Bracing As a Postoperative Adjunct to Multilevel Anterior Cervical Spine Surgery.

Authors:  Ian F Caplan; Saurabh Sinha; Benjamin Osiemo; Scott D McClintock; James M Schuster; Harvey Smith; Gregory Glauser; Nikhil Sharma; Ali K Ozturk; Zarina S Ali; Neil R Malhotra
Journal:  Int J Spine Surg       Date:  2020-04-30

4.  Severe cervical spondylotic myelopathy with complete neurological and neuroradiological recovery within a month after surgery.

Authors:  Marios Theologou; Dimitrios Zevgaridis; Theologos Theologou; Christos Tsonidis
Journal:  J Surg Case Rep       Date:  2016-11-24

5.  The Utility of Cervical Spine Bracing as a Postoperative Adjunct to Single-level Anterior Cervical Spine Surgery.

Authors:  Ian Caplan; Saurabh Sinha; James Schuster; Matthew Piazza; Gregory Glauser; Benjamin Osiemo; Scott McClintock; William C Welch; Nikhil Sharma; Ali Ozturk; Neil Rainer Malhotra
Journal:  Asian J Neurosurg       Date:  2019 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.